A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies
Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
Internal resorption in the most common cause of failure in FS pulpotomies in primary molars.
This has been attributed to the release of free eugenol from the zinc and eugenol mixture of
the base material over the pulp tissue. Zinc oxide-eugenol (ZOE) paste is the most common
base material placed over the infected pulp tissues during pulpotomies of primary molars,
however the evidence suggests that the eugenol component has been associated with the failure
of the vital pulp treatment in primary molars. Cavit (3M, US) is another base material that
contains Zinc-oxide, zinc sulphate, and calcium salts without eugenol. The effectiveness of
non-eugenol based Zinc oxide as a base material over ferric sulphate treated pulp has not
been explored. The hypothesis is that the non-eugenol based ZOE could be used as an alternate
to eugenol based ZOE and thereby avoid the radiological failures. Therefore, this randomized
controlled clinical split-mouth trial aimed to evaluate and compare the effect of eugenol and
non-eugenol based ZOE on the success of primary tooth pulpotomies where FS is used as a
medicament.